Benzinga | Jan 10, 2022 08:17AM EST

Morgan Stanley Upgrades Endava to Overweight, Raises Price Target to $185

Morgan Stanley analyst James Faucette upgrades Endava (NYSE:DAVA) from Equal-Weight to Overweight and raises the price target from $140 to $185.